We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.94%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$1.6B
AUM Growth
-$1.56B
Cap. Flow
-$1.16B
Cap. Flow %
-72.53%
Top 10 Hldgs %
22.78%
Holding
928
New
43
Increased
131
Reduced
69
Closed
237
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIONW
801
DELISTED
Lionheart III Corp Warrant
LIONW
-99,982
Closed -$1.03M
FRSG
802
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
-668,760
Closed -$6.72M
HERAW
803
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
-225,500
Closed -$2.28M
HERA
804
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
-1,230,373
Closed -$12.4M
FRSGW
805
DELISTED
First Reserve Sustainable Growth Corp. Warrant
FRSGW
-51,910
Closed -$522K
LION
806
DELISTED
Lionheart III Corp Class A Common Stock
LION
-201,254
Closed -$2.06M
LOKM.WS
807
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
-128,745
Closed -$1.29M
LOKM
808
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
-549,251
Closed -$5.52M
MLAI
809
DELISTED
McLaren Technology Acquisition Corp. Class A Common Stock
MLAI
-300,000
Closed -$3.06M
FTEV
810
DELISTED
FinTech Evolution Acquisition Group
FTEV
-743,340
Closed -$7.51M
HPX.WS
811
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
-93,765
Closed -$925K
MLAIW
812
DELISTED
McLaren Technology Acquisition Corp. Warrant
MLAIW
-150,000
Closed -$1.53M
EBACW
813
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
-66,566
Closed -$672K
EBAC
814
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
-308,841
Closed -$3.12M
IBER.WS
815
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
-150,000
Closed -$1.51M
IBER
816
DELISTED
Ibere Pharmaceuticals
IBER
-327,150
Closed -$3.3M
TPBA
817
DELISTED
TPB Acquisition Corporation I Class A Ordinary Share
TPBA
-14,250
Closed -$143K
ABGI
818
DELISTED
ABG Acquisition Corp. I
ABGI
-304,271
Closed -$3.07M
CPAQW
819
DELISTED
Counter Press Acquisition Corporation Warrant
CPAQW
-60,000
Closed -$616K
ANAC.WS
820
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
-137,499
Closed -$1.39M
DCRD
821
DELISTED
Decarbonization Plus Acquisition Corporation IV Class A Ordinary Share
DCRD
-1,022,467
Closed -$10.4M
ANAC
822
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
-818,155
Closed -$8.26M
CPAQ
823
DELISTED
Counter Press Acquisition Corporation Class A Ordinary Share
CPAQ
-122,393
Closed -$1.26M
FTAA
824
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
-720,164
Closed -$7.27M
FTAAW
825
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
-78,210
Closed -$790K

Similar funds

Radcliffe Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Radcliffe Capital Management held 928 positions worth $1.6B, down 49% from $3.16B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Radcliffe Capital Management withdrew a net $1.16B in Q1 2023, closing 237 positions and reducing 69 holdings. Its most notable exit was Berenson Acquisition Corp. I, an estimated $23.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 61% of assets, up from 50% a quarter earlier, followed by Industrials and Technology.

Against the trend, Radcliffe Capital Management opened a new position in M3-Brigade Acquisition II Corp. worth $3.97M.

  • Radcliffe Capital Management's largest Q1 2023 buy was M3-Brigade Acquisition II Corp.: 400,000 shares worth $3.97M.
  • Radcliffe Capital Management added most to CSLM Acquisition Corp. Class A Ordinary Share in Q1 2023, an estimated $6.55M increase.
  • Radcliffe Capital Management's biggest Q1 2023 reduction was Aeries Technology, cutting an estimated $11.4M.
  • Radcliffe Capital Management fully exited Berenson Acquisition Corp. I in Q1 2023, selling an estimated $23.1M.
  • Radcliffe Capital Management's ten largest holdings make up 23% of its $1.6B portfolio in Q1 2023.
  • Radcliffe Capital Management opened 43 new positions and closed 237 in Q1 2023.
  • Radcliffe Capital Management's portfolio value fell 49% quarter-over-quarter to $1.6B.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.